FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1621802391> ?p ?o ?g. }

• W1621802391 endingPage "11" @default.
• W1621802391 startingPage "403" @default.
• W1621802391 abstract "Our previous study demonstrated that an intraperitoneal injection of Diminazene Aceturate (DIZE) attenuated uveitis by activating ocular angiotensin-converting enzyme 2 (ACE2). Here, we investigated the anti-inflammatory effects on the ocular anterior segment of a topical administration of a DIZE solution and explored the downstream target molecules involved in the anti-inflammatory mechanism after ACE2 activation.Endotoxin-induced uveitis (EIU) in rats was induced by a subcutaneous injection of lipopolysaccharides (LPS, 200 μg) in 0.1 ml of sterile saline. DIZE (0.025, 0.05, or 0.1%) and dexamethasone (0.1%) solutions were applied topically (10 μl eyedrops) to both eyes 6X every two hours before and after LPS injection. The inflammation of the ocular anterior segment was observed and the clinical scores were evaluated 24 h after LPS injection. The total protein concentration and levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in the aqueous humor were determined. CD11b-positive cells adjacent to the iris ciliary body (ICB) were stained by immunohistochemistry. The mRNA levels of inflammatory cytokines and mediators, including IL-1β, TNF-α, COX-2, and iNOS or NF-κB subunit p65 in the ICB, were analyzed by real time RT-PCR. The protein expression of NF-κB p65 and the phosphorylated protein of p38 MAPK were detected by western blotting.A topical administration of DIZE decreased clinical scores and the total protein concentration, as well as TNF-α and IL-6 levels in the aqueous humor. Meanwhile, the mRNA levels of inflammatory cytokines and mediators, including IL-1β, TNF-α, COX-2, and iNOS in the ICB, were downregulated. DIZE reduced the recruitment of CD11b-positive cells adjacent to the ICB. Furthermore, DIZE downregulated the expressions of NF-κB subunit p65 at protein and mRNA levels and inhibited the phosphorylation of p38 MAPK protein in the ICB.A topical administration of DIZE suppressed ocular inflammation in EIU and decreased the levels of inflammatory cytokines. DIZE attenuated the activation of NF-κB and p38 MAPK in EIU, which may be associated with ACE2-mediated anti-inflammatory effects. Our data provided further evidence that DIZE may represent a novel class of drug for the management of ocular inflammation." @default.
• W1621802391 created "2016-06-24" @default.
• W1621802391 creator A5004045598 @default.
• W1621802391 creator A5013489732 @default.
• W1621802391 creator A5014912512 @default.
• W1621802391 creator A5051522793 @default.
• W1621802391 creator A5053161233 @default.
• W1621802391 creator A5064171998 @default.
• W1621802391 creator A5064648564 @default.
• W1621802391 date "2015-01-01" @default.
• W1621802391 modified "2023-09-29" @default.
• W1621802391 title "Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis." @default.
• W1621802391 cites W1232970536 @default.
• W1621802391 cites W148745300 @default.
• W1621802391 cites W1493720279 @default.
• W1621802391 cites W1517011065 @default.
• W1621802391 cites W1581555608 @default.
• W1621802391 cites W1584824123 @default.
• W1621802391 cites W1586043264 @default.
• W1621802391 cites W1620587130 @default.
• W1621802391 cites W1917885463 @default.
• W1621802391 cites W1976452827 @default.
• W1621802391 cites W1985312132 @default.
• W1621802391 cites W2007146260 @default.
• W1621802391 cites W2012144305 @default.
• W1621802391 cites W2029463298 @default.
• W1621802391 cites W2031099314 @default.
• W1621802391 cites W2031563447 @default.
• W1621802391 cites W2034831207 @default.
• W1621802391 cites W2037985064 @default.
• W1621802391 cites W2051107823 @default.
• W1621802391 cites W2060630008 @default.
• W1621802391 cites W2060898700 @default.
• W1621802391 cites W2064711537 @default.
• W1621802391 cites W2071621255 @default.
• W1621802391 cites W2086176437 @default.
• W1621802391 cites W2086677194 @default.
• W1621802391 cites W2092633725 @default.
• W1621802391 cites W2100409371 @default.
• W1621802391 cites W2104288547 @default.
• W1621802391 cites W2124460853 @default.
• W1621802391 cites W2125438637 @default.
• W1621802391 cites W2134842721 @default.
• W1621802391 cites W2140325630 @default.
• W1621802391 cites W2143059963 @default.
• W1621802391 cites W2158976339 @default.
• W1621802391 cites W2420035016 @default.
• W1621802391 cites W62851129 @default.
• W1621802391 cites W71051318 @default.
• W1621802391 cites W2107371634 @default.
• W1621802391 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4392833" @default.
• W1621802391 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25883526" @default.
• W1621802391 hasPublicationYear "2015" @default.
• W1621802391 type Work @default.
• W1621802391 sameAs 1621802391 @default.
• W1621802391 citedByCount "16" @default.
• W1621802391 countsByYear W16218023912015 @default.
• W1621802391 countsByYear W16218023912016 @default.
• W1621802391 countsByYear W16218023912017 @default.
• W1621802391 countsByYear W16218023912018 @default.
• W1621802391 countsByYear W16218023912019 @default.
• W1621802391 countsByYear W16218023912020 @default.
• W1621802391 countsByYear W16218023912021 @default.
• W1621802391 countsByYear W16218023912022 @default.
• W1621802391 countsByYear W16218023912023 @default.
• W1621802391 crossrefType "journal-article" @default.
• W1621802391 hasAuthorship W1621802391A5004045598 @default.
• W1621802391 hasAuthorship W1621802391A5013489732 @default.
• W1621802391 hasAuthorship W1621802391A5014912512 @default.
• W1621802391 hasAuthorship W1621802391A5051522793 @default.
• W1621802391 hasAuthorship W1621802391A5053161233 @default.
• W1621802391 hasAuthorship W1621802391A5064171998 @default.
• W1621802391 hasAuthorship W1621802391A5064648564 @default.
• W1621802391 hasConcept C126322002 @default.
• W1621802391 hasConcept C134018914 @default.
• W1621802391 hasConcept C164027704 @default.
• W1621802391 hasConcept C17991360 @default.
• W1621802391 hasConcept C185592680 @default.
• W1621802391 hasConcept C2776390293 @default.
• W1621802391 hasConcept C2776914184 @default.
• W1621802391 hasConcept C2777397205 @default.
• W1621802391 hasConcept C2778754761 @default.
• W1621802391 hasConcept C2780159080 @default.
• W1621802391 hasConcept C71924100 @default.
• W1621802391 hasConcept C98274493 @default.
• W1621802391 hasConceptScore W1621802391C126322002 @default.
• W1621802391 hasConceptScore W1621802391C134018914 @default.
• W1621802391 hasConceptScore W1621802391C164027704 @default.
• W1621802391 hasConceptScore W1621802391C17991360 @default.
• W1621802391 hasConceptScore W1621802391C185592680 @default.
• W1621802391 hasConceptScore W1621802391C2776390293 @default.
• W1621802391 hasConceptScore W1621802391C2776914184 @default.
• W1621802391 hasConceptScore W1621802391C2777397205 @default.
• W1621802391 hasConceptScore W1621802391C2778754761 @default.
• W1621802391 hasConceptScore W1621802391C2780159080 @default.
• W1621802391 hasConceptScore W1621802391C71924100 @default.
• W1621802391 hasConceptScore W1621802391C98274493 @default.
• W1621802391 hasLocation W16218023911 @default.

• next